Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH – Get Free Report) reached a new 52-week high during trading on Thursday. The company traded as high as $123.10 and last traded at $122.3040, with a volume of 594 shares. The stock had previously closed at $122.11.
VanEck Pharmaceutical ETF Trading Up 0.9%
The stock has a market capitalization of $1.18 billion, a PE ratio of 20.21 and a beta of 0.43. The business’s 50-day moving average is $112.77 and its two-hundred day moving average is $108.17.
VanEck Pharmaceutical ETF Cuts Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, October 6th. Stockholders of record on Thursday, October 1st were given a $0.36 dividend. The ex-dividend date of this dividend was Thursday, October 1st. This is a negative change from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.6248. This represents a $1.44 annualized dividend and a dividend yield of 1.2%.
Institutional Investors Weigh In On VanEck Pharmaceutical ETF
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Fluent Financial LLC acquired a new stake in VanEck Pharmaceutical ETF in the 2nd quarter valued at approximately $4,264,000. Independent Financial Group LLC acquired a new stake in shares of VanEck Pharmaceutical ETF in the first quarter worth $532,000. Adamsbrown Wealth Consultants LLC grew its stake in shares of VanEck Pharmaceutical ETF by 3.6% during the second quarter. Adamsbrown Wealth Consultants LLC now owns 154,114 shares of the company’s stock worth $16,852,000 after purchasing an additional 5,303 shares during the period. Avior Wealth Management LLC bought a new position in VanEck Pharmaceutical ETF during the third quarter worth about $1,685,000. Finally, Oppenheimer & Co. Inc. bought a new stake in shares of VanEck Pharmaceutical ETF in the 3rd quarter valued at about $711,000.
About VanEck Pharmaceutical ETF
The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.
Further Reading
- Five stocks we like better than VanEck Pharmaceutical ETF
- Matador Resources Insider Buying and the Case for a Dividend Stock Rebound
- Datadog’s Post-Earnings Sell-Off: A Buying Opportunity in Plain Sight?
- How Much of Tesla’s Robotaxi Future Is Already Priced In?
- 3 AI Infrastructure Plays Beyond Chipmakers
Receive News & Ratings for VanEck Pharmaceutical ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Pharmaceutical ETF and related companies with MarketBeat.com's FREE daily email newsletter.
